IP Verse

Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof

Patent No. EP3263571 (titled "Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof") was filed by Progenics Pharmaceuticals on Mar 28, 2008. The application was issued on Aug 23, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ISARPATENTAug 10, 2020ISARPATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3263571

PROGENICS PHARMACEUTICALS
Application Number
EP17172002A
Filing Date
Mar 28, 2008
Status
Patent Maintained As Amended
Jul 21, 2023
Publication Date
Aug 23, 2023
External Links
Slate, Register , Google Patents